NKure & CRISPR Partner to Advance CTX112 Cancer Therapy in India

NKure Therapeutics Private Limited, a Bengaluru-based cell and gene therapy startup committed to advancing innovative cell therapies, and CRISPR Therapeutics (Nasdaq: CRSP), a pioneer in gene-based medicines, today announced a strategic...

India Updates Biosimilar Rules, Focuses on 3Rs & Analytics

Comments have been invited from the stakeholders by the Central Drugs standard control organization (CDSCO) on the revised guidelines on biosimilars with updated requirements for marketing authorizations in the country

Johnson & Johnson Unveils Promising Tremfya Data for Ulcerative Colitis at DDW 2025

Johnson & Johnson announced compelling results from the phase 3 QUASAR long-term extension (LTE) study of Tremfya (guselkumab) in adults with moderately to severely active ulcerative colitis (UC). Presented at Digestive Disease Wee...

TPG to Acquire 35% Stake in SCHOTT Poonawalla from Serum Institute

SCHOTT Pharma, a global leader in drug containment and delivery solutions, has announced a binding agreement with TPG, a prominent alternative asset management firm, under which TPG will acquire a...

Govt Set to Roll Out Stricter Norms for Biosimilar Approvals

The Indian government is putting final touches on revised regulations to tighten quality requirements for biosimilar medicines, treatments derived from living cells applied in the treatment of cancers and...

Senores Pharma Acquires FDA-Approved Topiramate ANDA from Wockhardt

Topiramate hydrochloride tablets from Wockhard Ltd have been approved by Abbreviated New Drug Application, the achievement of the US FDA, announced by Ahmedabad-based Senores Pharmaceuticals Limited.

Akum's Breakthrough Tablet Brings Relief for Morning Sickness

Akums Drugs & Pharmaceuticals Ltd., a leading Indian pharmaceutical company, just got a patent for a new tablet that’s a game-changer for pregnant women struggling with nausea and vomiting. This exciting invention is here to make pregnancy a littl...

Commission Recommends Ban on In-Hospital Pharma Rep Visits

Pharmaceutical representatives will be prevented from meeting with doctors in person at hospitals, according to the major reform suggested by the Health Sector Reform Commission of Bangladesh...

FDA Grants Fast Track Status to IGI's ISB 2001 for Difficult-to-Treat Multiple Myeloma

IGI, a global, fully integrated clinical-stage biotechnology company focused on developing multispecifics™ in oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ISB 2001.

Mahajan Imaging Launches North Indias First 128 Slice Digital PET CT Scanner

Delhi NCR, May 6th , 2025: Mahajan Imaging & Labs, a pioneer in advanced diagnostics and medical imaging, inaugurated North India’s first 128 Slice Digital PET-CT -Omni Legend by GE HealthCare and state of the art P...

© 2025 India Pharma Outlook. All Rights Reserved.